Ali J. Satvat Insider Trading
Get free email notifications about insider trading for Ali J. Satvat.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali J. Satvat. Ali J. Satvat is a Director in Coherus BioSciences, Inc. ($CHRS) and a Director in Eidos Therapeutics, Inc. ($EIDX) and a Director in BridgeBio Pharma, Inc. ($BBIO).
Address: C/O COHERUS BIOSCIENCES, INC. 201 REDWOOD SHORES PARKWAY, SUITE 200 REDWOOD CITY 94065 CA
Companies in which Ali J. Satvat is an Insider
BridgeBio Pharma, Inc.
Trading Symbol: BBIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali J. Satvat: Director
Holdings: 0 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Coherus BioSciences, Inc.
Trading Symbol: CHRSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali J. Satvat: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 14 2020
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eidos Therapeutics, Inc.
Trading Symbol: EIDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ali J. Satvat: Director
Holdings: 24,575,501 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ali J. Satvat
Sentiment: All, BBIO, CHRS, EIDX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 10.99 | 79,702 | 875,925 | 79,702 | |
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 16.68 | 39,851 | 664,715 | 39,851 | |
Jan 28 2021 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 26.21 | 39,851 | 1,044,495 | 39,851 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 20.34 | 43,056 | 875,759 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 30.87 | 21,528 | 664,569 | 0 | |
Jan 28 2021 | EIDX | Eidos Therapeutics ... | Satvat Ali J. | Director | Option Exercise | D | 48.51 | 21,528 | 1,044,323 | 0 | |
Jun 04 2020 | BBIO | BridgeBio Pharma, ... | Satvat Ali J. | Director | Option Exercise | A | 29.00 | 112,422 | 3,260,238 | 112,422 |